Loading organizations...
Novel transcription factor medicines to reverse aging diseases.
Junevity has raised $20.0M across 2 funding rounds.
Junevity has raised $20.0M in total across 2 funding rounds.
Junevity has raised $20.0M in total across 2 funding rounds.
Junevity's investors include Godfrey Capital, Goldcrest Capital.
Junevity has raised $20.0M across 2 funding rounds. Most recently, it raised $10.0M Seed Extension in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 3, 2025 | $10.0M Seed Extension | Godfrey Capital, Goldcrest Capital | |
| Feb 13, 2025 | $10.0M Seed | Godfrey Capital, Goldcrest Capital |